Introduction
A leukemogenic retrovirus of clinical relevance (ie the human T cell leukemia/lymphoma virus type I, HTLV-I) was detected for the first time by Gallo and coworkers. 1 The virus was isolated from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. 1 Later, HTLV-I was found to be etiologically related to adult T cell leukemia, 2 and to other non-neoplastic neurological diseases, such as tropical spastic paraparesis/HTLV-I associated myelopathy (TSP/HAM). 3, 4 Human target cells can be infected in vitro when cocultured with lethally irradiated HTLV-I producer cells. 5 T lymphocytes are the preferential targets of virus infection, 1, 2, 5, 6 although other cell types are moderately susceptible to HTLV-I in vitro, 7, 8 including cells of neuroectodermal origin, 9 and leukemia cell lines at different stages of differentiation. 10 Phenotypic changes of surface antigens can be induced by virus infection. Coexpression of CD4 and CD8 antigens was observed in adult T cell leukemia (ATL) cells, 11 or ATL-derived cell lines, 12 and in purified CD8 + lymphocytes or peripheral blood mononuclear cells (PBMC) infected in vitro with HTLV-I. 13 Moreover, coexpression of myeloid and T cell markers was detected in ATL cells 14 and in cell lines derived from ATL, 15 or TSP/HAM 16 or from PBMC infected with HTLV-I. 15 In these cases, it was not clear whether the presence of both myeloid and lymphoid phenotype was the result of infection of a pre-existing biphenotypic cell population, 14 or of postinfection virus-dependent phenotypic changes. 17 Correspondence: G Graziani, Department of Neuroscience, University of Rome Tor Vergata, Via di Tor Vergata 135, 00133 Rome, Italy; Fax: 39-6 7259 6323 Received 8 January 1998; accepted 28 October 1998 The present study was undertaken to obtain more information about the possible mechanism underlying biphenotypic induction by HTLV-I in human PBMC. The experiments have been carried out with a highly purified CD4
+ T cell population, obtained from healthy donors, that has been infected in vitro with the virus. The results show the presence of cells with double myeloid and lymphoid phenotype, and suggest that the phenomenon is the result of an induction rather than a selection mechanism. 
Materials and methods

Monoclonal antibodies (mAb)
Isolation of CD4
+ cells
Freshly isolated PBMC from three healthy donors (hereafter referred to as PBMC A, B and C, respectively), separated by Ficoll-Hypaque density gradients (Pharmacia, Uppsala, Sweden), were deprived of monocytes by adherence on plastic dishes (2 h at 37°C) and of B lymphocytes by passage through nylon-wool column. Some of the cells were washed twice in RPMI 1640 (Gibco, Paisley, UK) and separated through immunomagnetic beads conjugated with specific anti-CD4 mAbs (Dynabeads, Oslo, Norway) according to a standard procedure, as described by Gaudernack et al. 18 Briefly, PBMC were mixed with anti-CD4-conjugated immunomagnetic beads at a final concentration of 20-40 × 10 6 PBMC/ml at a ratio of three beads per cell, on the basis of the expected number of cells expressing the specific membrane marker. Magnetic beads were previously washed in cold phosphate-buffered saline (PBS) containing 0.02% bovine serum albumin (BSA) (Sigma, St Louis, MO, USA) at 4°C. The mixture was incubated at 4°C for 30 min on a rotating wheel. Cell suspension was diluted 1:5 in PBS containing 2% fetal calf serum (FCS; Gibco) and the cells adherent to the beads were separated from the other cells by application of a magnet (Dynabeads). The positively selected subpopulation was then incubated overnight at 37°C in order to detach the magnetic beads. The purity of the cell population (ie A/CD4, B/CD4 and C/CD4 cells), was evaluated by flow cytometry.
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In vitro infection with HTLV-I
MT-2, a HTLV-I-producing cell line derived from virusinfected cord blood, 19 was grown in RPMI 1640 medium supplemented with 20% FCS, glutamine, penicillin-streptomycin (hereafter referred to as complete medium, CM), and split weekly. HTLV-I transmission was performed by coculturing PBMC or isolated CD4 + T cells with lethally irradiated (120 Gy, from a Cesium Gamma Cell 1000, Atomic Energy, Canada) MT-2 cells at an acceptor:donor ratio of 3:1. Cocultures were maintained in the presence of 100 U/ml of recombinant IL-2 (rIL-2, Hoffman-LaRoche, Basel, Switzerland) and split weekly. Control cultures, ie irradiated MT-2 cells, were kept in CM and did not show any evidence of growth throughout the time of observation.
Three immortalized cell lines were established 1 to 3 months after coculture of A/CD4, B/CD4 and C/CD4 cells with irradiated MT-2 cells. Immortalized lines were called A4HV, B4HV and C4HV, respectively.
HTLV-I-immortalized CD4 clones
To establish cell clones from A4HV immortalized cell line, a limiting dilution technique was used. The infected cells were cloned by limiting dilution at 0.5 cell per well in 96 roundbottomed plates (Flow Laboratories, Irvine, UK) in CM supplemented with rIL-2 (40 U/ml). The clones, obtained without any additional stimulation, were fed weekly and after 3-4 weeks, the growing clones were passed into 24-well plates. All clones were maintained in the presence of 20 U/ml of rIL-2.
Immunofluorescence staining and flow cytometric analysis
Freshly separated CD4 + T cells, cells from immortalized lines A4HV, B4HV, C4HV or clones of A4HV (1 × 10 6 ), were washed twice with PBS containing 0.1% BSA and 0.02% sodium azide (Sigma) (PBS-A) and then resuspended in 50 l of the same buffer containing saturating amounts of the appropriate FITC-or PE-conjugated mAb. Cells were then incubated at 4°C in the dark for 30 min, washed twice with PBS-A, resuspended in 1 ml of the same buffer and analyzed by flow cytometry. For two-color analysis cells were simultaneously incubated with FITC-conjugated and PE-conjugated mAbs. FITCconjugated and/or PE-conjugated mouse IgG 1 or IgG 2a were used as negative controls in single or double staining for each studied population. The labeled samples were analyzed using a FACScan flow cytometer (Becton Dickinson, Palo Alto, CA, USA). Data were collected on 1 × 10 4 viable cells as determined by forward and side angle light scatter. All data were recorded and analyzed using Lysis II software (Becton Dickinson).
Detection of HTLV-I proviral DNA and analysis of tax/rex mRNA in infected cells
High molecular weight (MW) DNA was extracted according to standard protocols. 20 Fifteen micrograms of DNA were digested with EcoRI for HTLV-I provirus detection. Digested DNA was electrophoresed through a 0.8% agarose gel and transferred to nylon membranes (Hybond-N, Amersham, Buckinghamshire, UK). Blots were hybridized in 5 × SSC (1 × SSC = NaCl 150 mM, Na Citrate 15 mM, pH 7), 0.5% SDS, 5% Denhardt's solution (0.02% Ficoll, 0.02% polyvinyl-pyrrolidone, 0.02% BSA fraction V, and 100 g/ml tRNA) at 65°C for 20 h. HTLV-I probe, corresponding to the full-length proviral DNA (9 kb, pMT-2 plasmid, kindly provided by Dr RC Gallo (Institute of Human Virology, Baltimore, MD, USA), 21 was labeled to high specific activity with ␣-32 P-dCTP (Amersham, specific activity 3000 Ci/mmol), using the nick translation method. 22 Filters were washed in 1 × SSC and 0.1% SDS and then in 0.1 × SSC and 0.1% SDS at 65°C for 30 min, according to the manufacturer's instructions. Autoradiography was performed with Kodak XAR-S films (Kodak, Rochester, NY, USA) at −80°C.
Polymerase chain reaction (PCR) analysis
One microgram of genomic DNA was subjected to 30 cycles of PCR amplification. Each cycle included a 15 s denaturation at 94°C, followed by a primer annealing step at 53°C for 30 s and a chain elongation step of 30 s at 68°C in a Perkin Elmer Cetus DNA thermal cycler (Perkin Elmer Cetus, Norwalk, CT, USA). After the last cycle, samples were further incubated at 72°C for 7 min, to ensure that the final extension step was complete. The primer pairs and probes used for HTLV-I tax and gag gene amplification are described in detail in Table 1 . Amplified DNA was analyzed by liquid hybridization (LH) using a ␥-32 P-end-labeled oligonucleotide specific probe. Hybridization was followed by electrophoresis on polyacrylamide gel and autoradiography.
Reverse transcriptase (RT)-PCR analysis
The method described by Chomczynsky and Sacchi 23 was used to isolate RNA. The primers used for RT or PCR, and the probe used for LH recognize specifically the tax/rex region of HTLV-I. The tax/rex region is expressed as a doubly spliced mRNA, and RPX3 and RPX4 primers (see Table 1 ) are located upstream and downstream, respectively, of the second junction site for tax/rex mRNA. The probe RPXPR1 (Table 1) corresponds to the sequences surrounding the second splice junction site at tax/rex mRNA.
Analysis of T cell receptor (TCR) ␤ gene arrangement
Arrangement of TCR ␤ chain gene was tested by Southern blot analysis of EcoRI digested genomic DNA. TCR ␤ probe, corresponding to the EcoRI-Hincll cDNA fragment, which hybridizes to the constant region of the ␤ chain of TCR, 24 were labeled with ␣-32 P-dCTP by using the random primer method. 25 Filters were treated as described above for Southern blot analysis to detect HTLV-I proviral DNA.
Results
Immunophenotype analysis of cells isolated by adherence to CD4-conjugated immunomagnetic beads
Freshly isolated T cells, obtained from A, B, and C donors (ie A/CD4, B/CD4, and C/CD4 cells) upon separation through immunomagnetic beads conjugated with anti-CD4 mAb, were assayed for immunoreactivity with mAb directed against CD3, CD4, CD13, CD33 and TCR-␣/␤ surface antigens. In all three cell preparations the expression of CD4 + subset was higher than 80% (Figure 1 ). The 
Presence of HTLV-I provirus in infected CD4
+
T cell lines
The presence of HTLV-I proviral DNA was tested in the three immortalized cell lines 20 weeks after infection. The results of PCR analysis followed by LH (Figure 3) , show that HTLV-I tax and gag region of proviral DNA were detectable in all the cell lines, thus confirming that immortalized cell lines are positive for the presence of the virus.
Immunophenotype analysis of infected T cell lines
As shown in Figure 4 (left panel) all three immortalized cultures were 100% positive for both CD3 and CD4. Moreover the two-color immunofluorescence analysis clearly demonstrated that a percentage of cells ranging from 14 to 54% or from 27 to 52% coexpressed TCR␣/␤ and CD13 or CD33, respectively ( Figure 4, right panel) .
Cells of A4HV line were cloned by limiting dilution at 0.5 cells per well in 96-well tissue culture plates. Clones were then stained or double-stained with FTIC-labeled anti-TCR-
Figure 3
Detection of HTLV-I tax and gag sequences in infected CD4 + T cell lines. CD4 + lymphocytes, obtained from peripheral blood of three different donors (A,B,C), were infected in vitro with HTLV-I. The derived immortalized cell lines (A4HV, B4HV and C4HV) were analyzed for HTLV-I detection by PCR. Genomic DNA (1 g) from A4HV (A), B4HV (B), C4HV (C), MT-2 (positive control, PC) cell lines and from normal PBMC (negative control, NC) was amplified using HTLV-I specific primers recognizing tax and gag regions (see Table  1 ). Amplified DNA was then analyzed by LH using specific 32 Plabeled oligonucleotides. Table 2 , show that all clones coexpressed the CD33/TCR ␣/␤ molecules at variable levels. 
␣/␤ mAb and PE-conjugated anti-CD33 mAb. The results of this analysis, illustrated in
Arrangement of TCR in 1/16 and 1/18 clones
To rule out the possibility that coexpression of lymphoid and myeloid phenotypes could have been the result of the overgrowth of myeloid cells which express T cell markers after HTLV-I infection, molecular analysis of the gene encoding for the ␤ chain of TCR was performed. Southern blot analysis was carried out with EcoRI-restricted genomic DNA, derived from HL-60 cells (promyelocytic cells which bear TCR in germline configuration), from MT-2 cells, from normal peripheral blood lymphocytes and from 1/16 or 1/18 clones. The results ( Figure  5 , lane 1) demonstrate that control HL60 cells contain the TCR ␤ gene in germline configuration since two bands of 12 and 4 kb, corresponding to the germline configuration of the C-␤1 and C-␤2 alleles were detected. In contrast, the T cell-derived MT-2 line displayed a monoclonal rearrangement of the C␤1 allele visible as a distinct band different from the germline 12 kb band ( Figure 5, lane 2) .
In the normal peripheral blood lymphocytes, the 12 kb band disappeared as a result of polyclonal rearrangements of the C-␤1 allele ( Figure 5, lane 5) .
Clone 1/16 and 1/18 showed the same deletion of constant region and did not present the TCR ␤ gene in the germline configuration ( Figure 5, lanes 3 and 4, respectively) . These results indicate that 1/16 and 1/18 clones did not arise from cells of myeloid origin and confirm their origin from the same T cell clone.
Figure 4
Expression of CD3, CD4, TCR␣/␤, CD13 and CD33 in A4HV, B4HV and C4HV cell lines. The immortalized cell lines A4HV, B4HV, and C4HV (panels a, b and c, respectively) were single stained with anti-CD3 (FITC) or anti-CD4 (PE) mAbs or double stained with anti-CD33 (PE)/anti-TCR (FITC), or anti-CD13 (PE)/anti-TCR (FITC) mAbs. Negative controls were set up as described in Figures 1 and 2 . The percentage of cells expressing both CD13 and TCR, or both CD33 and TCR is indicated. 
Expression of HTLV-I tax/rex gene in infected 1/16 and 1/18 clones
RNA (1 g) extracted from infected clones 1/16 and 1/18 was subjected to RT-PCR by using RPX3 and RPX4 primers. The amplified DNA was analyzed by LH using ␥-32 P-labeled oligonucleotide probe surrounding the second splice junction site of tax-rex mRNA. Total RNA from MT-2 cells, which express HTLV-I proteins, was used as positive control. Tax/rex mRNA was detected in infected clones, thus indicating that HTLV-I provirus is actively transcribed (Figure 6 ).
Integration pattern of HTLV-I provirus in infected 1/16 and 1/18 clones
Southern blot analysis of genomic DNA (15 g), was performed after digestion with EcoRI which does not cleave within HTLV-I proviral DNA. Each site of HTLV-I integration is represented by a unique EcoRI restriction fragment, revealed by hybridization with the HTLV-I probe. Therefore the results, illustrated in Figure 7 , point out that HTLV-I integration sites in 1/16 and 1/18 clones are different from those of virusdonor MT-2 cells. Two distinguishable fragments, containing HTLV-I sequences were observed in 1/16 clone. Furthermore, 1/18 clone showed cellular site of integration of HTLV-I proviral DNA different from that of 1/16 clone.
Discussion
The present study shows that in vitro infection of CD4 + T lymphocytes from healthy donors with HTLV-I results in immortalized T cell lines expressing anomalous myeloid cell markers, ie CD13 and CD33 antigens. The data confirm previous observations on the appearance of myeloid markers in bulk T cell receptor gene arrangement. Southern blot analysis of EcoRI-digested genomic DNA was performed using germline control HL-60 cells (1); MT-2 cells (2); 1/18 clone (3); 1/16 clone (4) and normal peripheral blood lymphocytes (5). Hybridization was carried out using a probe corresponding to the constant region of the ␤ chain of TCR. Arrows indicate the two main germline bands of 12 and 4 kb, respectively.
Figure 6
Detection of HTLV-I tax/rex transcript in infected clones. RNA (1 g) extracted from A4HV-derived clones 1/16 and 1/18, MT-2 cells and PBMC (NC) was subjected to RT-PCR by using RPX3 and RPX4 primers which are located upstream and downstream, respectively, of the second splice junction site of tax/rex mRNA. Amplified DNA was analyzed by LH using a HTLV-I specific probe surrounding the second splice junction site of tax/rex mRNA. (−), RNA samples incubated without RT; (+), RNA samples incubated in the presence of RT.
cultures of cord blood mononuclear cells infected in vitro with HTLV-I, 16, 17 or in cell lines established in vitro from leukemic patients positive for HTLV-I. 15 The possibility that HTLV-I might have infected the few CD33/TCR␣/␤ double positive cells present in the original CD4
+ population cannot be entirely ruled out. However, the data favor the hypothesis that Integration pattern of HTLV-I in 1/16 and 1/18 infected clones. Genomic DNA (15 g) was digested by EcoRI and subjected to Southern blot analysis. Filters were hybridized with the 32 P-labeled HTLV-I probe corresponding to the entire proviral DNA. Lamda HindIII DNA digests were used as molecular weight markers. Lanes 1, MT-2 cells; 2, clone 1/18; 3, clone 1/16; 4, normal peripheral blood lymphocytes (negative control).
the phenotypic changes of CD4 + cells infected with HTLV-I, originated from induction rather than selection mechanism. This is supported by the following considerations: (1) the starting T cell population, target of HTLV-I infection, was isolated on immunomagnetic beads, and therefore it can be considered reasonably pure, as confirmed by flow cytometric analysis ( Figure 1 In addition the present results support the fact that the cellular target infected by the retrovirus was of T origin rather than of myeloid origin. In fact, the molecular analysis of the gene encoding for the ␤ chain of TCR in HTLV-I infected clones indicate that the TCR ␤ gene was not in the germline configuration as described for cells of lymphoid origin.
The results of the analysis of HTLV-I integration and expression in immortalized lines and in sublines obtained by cloning of the parental lines, showed that: (1) all cell lines tested were positive for the presence of proviral sequences of HTLV-I; (2) the integration pattern of HTLV-I was different in two of various immortalized clones tested, thus indicating different pattern of virus integration in the parental cell line. It follows that the virus generated a number of different immortalized clones, suggesting that in these experimental conditions, virus infection and immortalization was a relatively frequent event. This is in line with the well known tropism of HTLV-I for CD4 + T lymphocytes; 26 (3) the tested clones expressed the tax/rex region of HTLV-I, that it is involved in the transactivation of cellular or viral genes. 27 A number of cellular genes has been found to be activated by HTLV-I infection, such as IL-1, IL-2, IL-2 receptor, IL-3, IL-6, GM-CSF, TNF, c-fos, c-sis, c-myc. [28] [29] [30] [31] The molecular bases for this phenomenon reside in the transactivation activity of tax. 32 Therefore, the expression of myeloid markers in CD4 + T cells immortalized by HTLV-I, could reasonably be interpreted on the basis of induction phenomenon presumably provoked by transactivation activity of tax-rex products. Expression of CD33 antigen on normal lymphocytes has been described in T cells either CD4 + or CD8 + , activated with anti-CD3 mAb plus recombinant IL-2. 33 It has been hypothesized that lymphocytes might express CD33 during inflammatory process in vivo. 34 The meaning and the possible role in leukemogenesis of phenotypic changes occurring in transformed cells, are not presently known. Further investigations are required to test whether the presence of myeloid cell proteins on transformed lymphocytes would confer or would be associated with neoplastic properties different from those of single-phenotype leukemic cells. Actually, a number of clinical studies have shown that double phenotype is associated with a more aggressive disease. In particular there are reports indicating that expression of myeloid markers (ie CD13, CD33) by leukemic blasts in patients bearing B cell chronic lymphocytic leukemia, increased in the course of disease progression. Notably, neoplastic cells of the same patients were negative for myeloid markers at diagnosis and at an early stage of the disease. 33 Other investigators found that the expression of CD13 and CD33 was associated with a more diffuse pattern of lymphoid leukemic cell infiltration in the bone marrow. 35 Actually, acute type of adult T cell leukemia is frankly aggressive. 36 It cannot therefore be ruled out that this biphenotypic pattern would play a certain role in tumor aggressiveness.
It has been shown that HTLV-I infection induces not only the production of soluble factors or up-regulation of cytokine receptors, but also the expression of adhesion molecules and integrins. Tumor aggressiveness of infected cells is related to the expression of different adhesion molecules. Positivity for adhesion molecules such as CD11b, in association with myeloid markers such as CD13 and CD33, is correlated with a poor prognosis. 37 High expression of integrins might be relevant for the pathogenicity of HTLV-I, since this could favor proliferation and a remarkable homing of infected cells in target tissues. Recent works have assessed an increased expression of ␣4-␤1 and ␣5-␤1 molecules in T cell lines transformed by HTLV-I. 38 In agreement with these data, we have found that the culture A4HV, showed a higher expression of the ␣-4 chain compared to the uninfected counterpart (data not shown).
Thus expression of myeloid and lymphoid markers together with virus-mediated modulation of adhesion molecules might contribute to ATL aggressiveness.
In conclusion, the present study pointed out that purified CD4 + T lymphocytes can be immortalized by HTLV-I, and induced to express a biphenotypic pattern.
It follows that coexpression of myeloid and lymphoid markers in HTLV-I infected cells, together with up-regulation of adhesion molecules, could be predictive of aggressive malignancy, consistent with the biological characteristics of HTLV-I-induced T cell leukemia.
